Clinical Charts
Emetogenic Potential of Antineoplastic Agents
Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.
Substantial improvement observed through month 12, which persisted through month 60, but lessened with fewer treatments